These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 22439769)

  • 1. Novel approaches to flavivirus drug discovery.
    Botting C; Kuhn RJ
    Expert Opin Drug Discov; 2012 May; 7(5):417-28. PubMed ID: 22439769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Flaviviruses by Targeting a Conserved Pocket on the Viral Envelope Protein.
    de Wispelaere M; Lian W; Potisopon S; Li PC; Jang J; Ficarro SB; Clark MJ; Zhu X; Kaplan JB; Pitts JD; Wales TE; Wang J; Engen JR; Marto JA; Gray NS; Yang PL
    Cell Chem Biol; 2018 Aug; 25(8):1006-1016.e8. PubMed ID: 29937406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses.
    Kampmann T; Yennamalli R; Campbell P; Stoermer MJ; Fairlie DP; Kobe B; Young PR
    Antiviral Res; 2009 Dec; 84(3):234-41. PubMed ID: 19781577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions.
    Cannalire R; Tarantino D; Piorkowski G; Carletti T; Massari S; Felicetti T; Barreca ML; Sabatini S; Tabarrini O; Marcello A; Milani M; Cecchetti V; Mastrangelo E; Manfroni G; Querat G
    Antiviral Res; 2019 Jul; 167():6-12. PubMed ID: 30849420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small Molecules Targeting the Flavivirus E Protein with Broad-Spectrum Activity and Antiviral Efficacy in Vivo.
    Li PC; Jang J; Hsia CY; Groomes PV; Lian W; de Wispelaere M; Pitts JD; Wang J; Kwiatkowski N; Gray NS; Yang PL
    ACS Infect Dis; 2019 Mar; 5(3):460-472. PubMed ID: 30608640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current approaches in antiviral drug discovery against the Flaviviridae family.
    Baharuddin A; Hassan AA; Sheng GC; Nasir SB; Othman S; Yusof R; Othman R; Rahman NA
    Curr Pharm Des; 2014; 20(21):3428-44. PubMed ID: 24001228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single-amino acid substitution in West Nile virus 2K peptide between NS4A and NS4B confers resistance to lycorine, a flavivirus inhibitor.
    Zou G; Puig-Basagoiti F; Zhang B; Qing M; Chen L; Pankiewicz KW; Felczak K; Yuan Z; Shi PY
    Virology; 2009 Feb; 384(1):242-52. PubMed ID: 19062063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of Immunologically Inspired Small Molecules That Target the Viral Envelope Protein.
    Lian W; Jang J; Potisopon S; Li PC; Rahmeh A; Wang J; Kwiatkowski NP; Gray NS; Yang PL
    ACS Infect Dis; 2018 Sep; 4(9):1395-1406. PubMed ID: 30027735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flaviviruses are sensitive to inhibition of thymidine synthesis pathways.
    Fischer MA; Smith JL; Shum D; Stein DA; Parkins C; Bhinder B; Radu C; Hirsch AJ; Djaballah H; Nelson JA; Früh K
    J Virol; 2013 Sep; 87(17):9411-9. PubMed ID: 23824813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors compounds of the flavivirus replication process.
    García LL; Padilla L; Castaño JC
    Virol J; 2017 May; 14(1):95. PubMed ID: 28506240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in flavivirus antiviral drug discovery and vaccine development.
    Ray D; Shi PY
    Recent Pat Antiinfect Drug Discov; 2006 Jan; 1(1):45-55. PubMed ID: 18221133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small molecule drug discovery for Dengue and West Nile viruses: applying experience from hepatitis C virus.
    Parkinson T; Pryde DC
    Future Med Chem; 2010 Jul; 2(7):1181-203. PubMed ID: 21426163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3',5'Di-O-trityluridine inhibits in vitro flavivirus replication.
    De Burghgraeve T; Selisko B; Kaptein S; Chatelain G; Leyssen P; Debing Y; Jacobs M; Van Aerschot A; Canard B; Neyts J
    Antiviral Res; 2013 May; 98(2):242-7. PubMed ID: 23470860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broad-spectrum inhibitor of viruses in the Flaviviridae family.
    Ojwang JO; Ali S; Smee DF; Morrey JD; Shimasaki CD; Sidwell RW
    Antiviral Res; 2005 Nov; 68(2):49-55. PubMed ID: 16199098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug.
    Mastrangelo E; Pezzullo M; De Burghgraeve T; Kaptein S; Pastorino B; Dallmeier K; de Lamballerie X; Neyts J; Hanson AM; Frick DN; Bolognesi M; Milani M
    J Antimicrob Chemother; 2012 Aug; 67(8):1884-94. PubMed ID: 22535622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular targets for flavivirus drug discovery.
    Sampath A; Padmanabhan R
    Antiviral Res; 2009 Jan; 81(1):6-15. PubMed ID: 18796313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New developments in flavivirus drug discovery.
    Kok WM
    Expert Opin Drug Discov; 2016; 11(5):433-45. PubMed ID: 26966889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput screening for the identification of small-molecule inhibitors of the flaviviral protease.
    Balasubramanian A; Manzano M; Teramoto T; Pilankatta R; Padmanabhan R
    Antiviral Res; 2016 Oct; 134():6-16. PubMed ID: 27539384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleic acid-based inhibition of flavivirus infections.
    Stein DA; Shi PY
    Front Biosci; 2008 Jan; 13():1385-95. PubMed ID: 17981637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Small-Molecule Oligosaccharyltransferase Inhibitor with Pan-flaviviral Activity.
    Puschnik AS; Marceau CD; Ooi YS; Majzoub K; Rinis N; Contessa JN; Carette JE
    Cell Rep; 2017 Dec; 21(11):3032-3039. PubMed ID: 29241533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.